Dissemin is shutting down on January 1st, 2025

Published in

Springer, Investigational New Drugs, 3(39), p. 829-835, 2021

DOI: 10.1007/s10637-020-01043-9

Links

Tools

Export citation

Search in Google Scholar

The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial

Journal article published in 2021 by Jeffrey A. How ORCID, Amir Jazaeri, Shannon N. Westin, Anil K. Sood, Lois M. Ramondetta, Mingxuan Xu, Abdulrahman Abonofal, Daniel D. Karp, Vivek Subbiah, Bettzy Stephen ORCID, Jordi A. Rodon ORCID, Fei Yang, Aung Naing ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO